FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386569162> ?p ?o ?g. }

• W4386569162 abstract "Abstract Background Parkinson’s disease (PD) is a well-known neurodegenerative disease that is usually caused by the progressive loss of dopamine neurons and the formation of Lewy vesicles. 3,4-Methylenedioxymethamphetamine (MDMA) has been reported to cause damage to human substantia nigra neurons and an increased risk of PD, but the exact molecular mechanisms need further investigation. Methods MPTP- and MPP+-induced PD cells and animal models were treated with Nissl staining to assess neuronal damage in the substantia nigra (SN) area; immunohistochemistry to detect TH expression in the SN; TUNEL staining to detect apoptosis in the SN area; Western blotting to detect the inflammatory factors NF-κB, TNF-α, IL-6 and mitogen-activated protein kinase kinase kinase 3 (MEKK3); Griess assay for NO; RT‒qPCR for metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and miR-124 expression; Cell proliferation was assessed by CCK-8. Dual luciferase reporter genes were used to verify targeting relationships. Results MDMA promoted MALAT1 expression, and knockdown of MALAT1 alleviated the MDMA-induced inhibition of SH-SY5Y cell proliferation, inflammation, NO release, SN neuronal injury, and TH expression inhibition. Both inhibition of miR-124 and overexpression of MEKK3 reversed the neuroprotective effects exhibited by knockdown of MALAT1. Conclusion MDMA promotes MALAT1 expression and inhibits the targeted downregulation of MEKK3 by miR-124, resulting in upregulation of the expression of MEKK3 and finally jointly promoting PD progression." @default.
• W4386569162 created "2023-09-10" @default.
• W4386569162 creator A5002454695 @default.
• W4386569162 creator A5043146170 @default.
• W4386569162 creator A5048686395 @default.
• W4386569162 creator A5061354916 @default.
• W4386569162 creator A5064306241 @default.
• W4386569162 creator A5078725609 @default.
• W4386569162 date "2023-09-09" @default.
• W4386569162 modified "2023-10-16" @default.
• W4386569162 title "MDMA targets miR-124/MEKK3 via MALAT1 to promote Parkinson’s disease progression" @default.
• W4386569162 cites W1739153474 @default.
• W4386569162 cites W1827337539 @default.
• W4386569162 cites W1996816024 @default.
• W4386569162 cites W2139296565 @default.
• W4386569162 cites W2330037785 @default.
• W4386569162 cites W2605668356 @default.
• W4386569162 cites W2766390417 @default.
• W4386569162 cites W2783220505 @default.
• W4386569162 cites W2810537181 @default.
• W4386569162 cites W2892784410 @default.
• W4386569162 cites W2904854839 @default.
• W4386569162 cites W2913343478 @default.
• W4386569162 cites W2936191024 @default.
• W4386569162 cites W2948799212 @default.
• W4386569162 cites W2950015557 @default.
• W4386569162 cites W2953791151 @default.
• W4386569162 cites W2955008892 @default.
• W4386569162 cites W2958758308 @default.
• W4386569162 cites W2963028828 @default.
• W4386569162 cites W2981625521 @default.
• W4386569162 cites W2986926875 @default.
• W4386569162 cites W2988565555 @default.
• W4386569162 cites W3000228962 @default.
• W4386569162 cites W3007587602 @default.
• W4386569162 cites W3011884642 @default.
• W4386569162 cites W3014945289 @default.
• W4386569162 cites W3015839972 @default.
• W4386569162 cites W3029178129 @default.
• W4386569162 cites W3082611265 @default.
• W4386569162 cites W3087943057 @default.
• W4386569162 cites W3093692434 @default.
• W4386569162 cites W3118988966 @default.
• W4386569162 cites W3121801445 @default.
• W4386569162 cites W3125203577 @default.
• W4386569162 cites W3126284132 @default.
• W4386569162 cites W3184426551 @default.
• W4386569162 cites W4220759817 @default.
• W4386569162 doi "https://doi.org/10.1007/s11033-023-08775-w" @default.
• W4386569162 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37688681" @default.
• W4386569162 hasPublicationYear "2023" @default.
• W4386569162 type Work @default.
• W4386569162 citedByCount "0" @default.
• W4386569162 crossrefType "journal-article" @default.
• W4386569162 hasAuthorship W4386569162A5002454695 @default.
• W4386569162 hasAuthorship W4386569162A5043146170 @default.
• W4386569162 hasAuthorship W4386569162A5048686395 @default.
• W4386569162 hasAuthorship W4386569162A5061354916 @default.
• W4386569162 hasAuthorship W4386569162A5064306241 @default.
• W4386569162 hasAuthorship W4386569162A5078725609 @default.
• W4386569162 hasBestOaLocation W43865691621 @default.
• W4386569162 hasConcept C104317684 @default.
• W4386569162 hasConcept C127561419 @default.
• W4386569162 hasConcept C134018914 @default.
• W4386569162 hasConcept C137183658 @default.
• W4386569162 hasConcept C153911025 @default.
• W4386569162 hasConcept C173396325 @default.
• W4386569162 hasConcept C185592680 @default.
• W4386569162 hasConcept C190283241 @default.
• W4386569162 hasConcept C25498285 @default.
• W4386569162 hasConcept C2780938664 @default.
• W4386569162 hasConcept C502942594 @default.
• W4386569162 hasConcept C513476851 @default.
• W4386569162 hasConcept C55493867 @default.
• W4386569162 hasConcept C86803240 @default.
• W4386569162 hasConcept C95444343 @default.
• W4386569162 hasConcept C98274493 @default.
• W4386569162 hasConceptScore W4386569162C104317684 @default.
• W4386569162 hasConceptScore W4386569162C127561419 @default.
• W4386569162 hasConceptScore W4386569162C134018914 @default.
• W4386569162 hasConceptScore W4386569162C137183658 @default.
• W4386569162 hasConceptScore W4386569162C153911025 @default.
• W4386569162 hasConceptScore W4386569162C173396325 @default.
• W4386569162 hasConceptScore W4386569162C185592680 @default.
• W4386569162 hasConceptScore W4386569162C190283241 @default.
• W4386569162 hasConceptScore W4386569162C25498285 @default.
• W4386569162 hasConceptScore W4386569162C2780938664 @default.
• W4386569162 hasConceptScore W4386569162C502942594 @default.
• W4386569162 hasConceptScore W4386569162C513476851 @default.
• W4386569162 hasConceptScore W4386569162C55493867 @default.
• W4386569162 hasConceptScore W4386569162C86803240 @default.
• W4386569162 hasConceptScore W4386569162C95444343 @default.
• W4386569162 hasConceptScore W4386569162C98274493 @default.
• W4386569162 hasLocation W43865691621 @default.
• W4386569162 hasLocation W43865691622 @default.
• W4386569162 hasOpenAccess W4386569162 @default.
• W4386569162 hasPrimaryLocation W43865691621 @default.
• W4386569162 hasRelatedWork W2024344351 @default.
• W4386569162 hasRelatedWork W2346343701 @default.
• W4386569162 hasRelatedWork W2494327966 @default.

• next